These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34027123)

  • 21. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B.
    Zhong LK; Zhang G; Luo SY; Yin W; Song HY
    J Clin Lab Anal; 2020 Jul; 34(7):e23270. PubMed ID: 32363594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Fibrosis Evaluated With Transient Elastography in 35 Children With Chronic Hepatitis C Virus Infection.
    Pokorska-Śpiewak M; Dobrzeniecka A; Lipińska M; Tomasik A; Aniszewska M; Marczyńska M
    Pediatr Infect Dis J; 2021 Feb; 40(2):103-108. PubMed ID: 33021594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection.
    Rungta S; Kumari S; Deep A; Verma K; Swaroop S
    J Family Med Prim Care; 2021 Nov; 10(11):4082-4088. PubMed ID: 35136771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection.
    Zhang H; Shi X; Wang L; Zeng Y; Kang X; Huang L
    J Clin Lab Anal; 2021 Sep; 35(9):e23960. PubMed ID: 34403524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?
    Gounder PP; Haering C; Bruden DJT; Townshend-Bulson L; Simons BC; Spradling PR; McMahon BJ
    J Clin Gastroenterol; 2018 Jan; 52(1):60-66. PubMed ID: 27875352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Hu PJ; Bair MJ
    J Microbiol Immunol Infect; 2020 Aug; 53(4):542-549. PubMed ID: 31831303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum biomarkers as an alternative to vibration controlled transient elastography in liver fibrosis staging in chronic hepatitis C.
    Debnath P; Nair S; Rathi P; Junare P; Jain S; Chandnani S; Singh A; Contractor Q
    Acta Gastroenterol Belg; 2021; 84(1):43-50. PubMed ID: 33639692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Huang R; Rao H; Yang M; Gao Y; Wang J; Jin Q; Ma D; Wei L
    Dig Dis Sci; 2020 May; 65(5):1491-1500. PubMed ID: 31654313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography.
    Papadopoulos N; Vasileiadi S; Papavdi M; Sveroni E; Antonakaki P; Dellaporta E; Koutli E; Michalea S; Manolakopoulos S; Koskinas J; Deutsch M
    Ann Gastroenterol; 2019; 32(5):498-503. PubMed ID: 31474797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
    Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
    Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis.
    Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S
    Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patients.
    Verlinden W; Bourgeois S; De Maeyer M; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    Acta Gastroenterol Belg; 2015 Dec; 78(4):373-80. PubMed ID: 26712046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease].
    He SL; Li SJ; Liu M; Ouyang WX; Chen WJ; Zheng X; Jiang T; Tan YF; Kang Z; Qin XM; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):81-86. PubMed ID: 35152674
    [No Abstract]   [Full Text] [Related]  

  • 36. FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B.
    Ding D; Li H; Liu P; Chen L; Kang J; Zhang Y; Ma D; Chen Y; Luo J; Meng Z
    Int J Clin Exp Med; 2015; 8(11):20876-82. PubMed ID: 26885013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hepatic injury in chronic hepatitis B and C using APRI and FIB-4 indices compared to fibroscan results.
    Najafi N; Razavi A; Jafarpour H; Raei M; Azizi Z; Davoodi L; Abdollahi A; Frouzanian M
    Ann Med Surg (Lond); 2024 Jul; 86(7):3841-3846. PubMed ID: 38989210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of simple serum-based tests to exclude cirrhosis prior to hepatitis C treatment in non-hospital settings in Australia.
    Burrage L; Zimmerman H; Higgins S; Param K; Orme C; Mitchell J; O'Beirne J
    Intern Med J; 2021 Apr; 51(4):533-539. PubMed ID: 31994285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
    Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
    World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.